
Enable job alerts via email!
Generate a tailored resume in minutes
Land an interview and earn more. Learn more
A biotechnology company in Singapore is seeking a Synthetic Organic Chemist to contribute to the development of cancer therapies. This role involves molecular design, synthesis assessment, and project management within an innovative cross-functional team. Ideal candidates will have a PhD or relevant master's with extensive industry experience. Strong attention to detail and communication skills are essential. Competitive compensation and benefits are provided.
Headquartered in Seattle and Singapore, Callio Therapeutics is focused on realizing the promise of multi‑payload antibody‑drug conjugates (ADCs) to transform cancer patient outcomes. Significantly backed by the industry’s top investors, the company is developing next‑generation, multi‑payload ADCs that feature differentiated payload and linker technologies to maximize therapeutic benefit by enabling targeted delivery of multi agents to tumor cells. Callio Therapeutics is focused on driving its HER2‑targeted dual‑payload ADC to the clinic, gathering key clinical data, and progressing its pipeline assets.
We are looking for a Synthetic Organic Chemist / Medicinal Chemist in ADC Chemistry who will work closely with Antibody‑Drug Conjugate team members as well as other cross‑functional and external parties, such as CROs. As a Synthetic Organic Chemist / Medicinal Chemist, you will support the design, making and assessment of linker‑payload molecules in our ADCs.
Education & experience: Minimum qualifications – PhD in organic / medicinal chemistry (preferred), or a Masters degree in organic / medicinal chemistry with a minimum of 6 years, predominantly in industry / CRO setting.